Form EFFECT Silexion Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 29, 2025 |
| Accession Number: | 0001178913-25-001991 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- STATEMENT FROM CITIZENS BANK OF EDMOND CHAIRMAN, PRESIDENT, AND CEO JILL CASTILLA ON MAIN STREET GROWTH AT THE G20
- Brighton Moving Company, Better Life Moving, Expands Capacity Ahead of the September Moving Rush
- PLAY PALM ANGELS EXPANDS ITS U.S. RETAIL FOOTPRINT AT PACSUN
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
